WADDELL & ASSOCIATES, LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 364 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
WADDELL & ASSOCIATES, LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$455,505
+10.6%
10,0420.0%0.07%
+11.7%
Q2 2023$412,023
+14.8%
10,0420.0%0.06%
+7.1%
Q1 2023$358,901
-5.4%
10,0420.0%0.06%
-12.5%
Q4 2022$379,286
-14.6%
10,0420.0%0.06%
-25.6%
Q3 2022$444,000
+19.4%
10,0420.0%0.09%
+13.2%
Q2 2022$372,000
-7.2%
10,0420.0%0.08%
+24.6%
Q2 2021$401,00010,0420.06%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Bellevue Group AG 9,347,926$313,529,0003.18%
Sicart Associates LLC 291,254$9,769,0002.66%
Camber Capital Management LP 2,500,000$83,850,0002.58%
SECTOR GAMMA AS 263,870$8,850,0001.76%
Parkman Healthcare Partners LLC 136,380$4,574,0001.16%
Eversept Partners, LP 450,501$15,109,8041.05%
SPHERA FUNDS MANAGEMENT LTD. 350,000$11,739,0000.99%
TANAKA CAPITAL MANAGEMENT INC 16,661$559,0000.80%
Sonora Investment Management, LLC 163,703$5,491,0000.69%
ARK Investment Management 8,511,384$285,472,0000.69%
View complete list of IONIS PHARMACEUTICALS INC shareholders